Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

DUODENAL ULCER

DOI: https://doi.org/10.29296/25879979-2019-07-07
Download full text PDF
Issue: 
7
Year: 
2019

V.V. Skvortsov, MD; M.V. Lunkov; E.M. Skvortsova Volgograd State Medical University 1, Pavshikh Boitsov Square, Volgograd 400066, Russian Federation

The paper highlights the etiology, classification, pathogenesis, and clinical symptoms of duodenal ulcer, and approaches to its diagnosis and effective complex therapy.
Keywords: 
duodenal ulcer
bleeding
defense mechanisms
aggression factors
proton pump inhibitors
Helicobacter pylori

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Malfertheiner P., Megraud F., O’Morain C. et al. Management of Helicobacter pylori infection– the Maastricht V/Florence Consensus. Report. Gut. 2017; 66 (1): 6–30.
  2. Fallone C.A., Chiba N., van Zanten S.V. et al. The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology. 2016; 151 (1): 51–69.
  3. Graham D., Laine L., Toronto H. pylori Consensus Recommendations in Context. Gastroenterology. 2016; 151 (1): 9–12.
  4. Chey W.D., Leontiadis G.I., Howden C.W., Moss S.F. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am. J. Gastroenterol. 2017; 112 (2): 212–39.
  5. Sugano K., Tack J., Kuipers E.J. et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015; 64: 1353–67.
  6. Stanghellini V., Chan F., Hasler W.L. et al. Gastroduo denal disorders. Gastroenterology. 2016; 150: 1380–92.
  7. Moayyedi P., Lacy B.E., Andrews S.N. et al. American College of Gastroenterology and Canadian Association of Gastroenterology guidelines on the management of dyspepsia. Am. J. Gastroenterol. 2017; 112: 988–1013.
  8. Pimanov S.I., Makarenko E.V. Diagnostika i lechenie infektsii Helicobacter pylori: polozhenija Maastriht V Florentijskogo konsensusa i kommentarii: posobie dlja vrachej. Minsk: Chetyre chetverti, 2017; 90.
  9. Cheng Y.-J., Nie X.-Y., Chen X.-M. The Role of Macrolide Antibiotics in Increasing Cardio vascular Risk. J. Am. Coll Cardiol. 2015; 66: 2173–84.
  10. Pimanov S.I., Silivonchik N.N. Funktsional'nye zheludochno-kishechnye rasstrojstva: Rimskij IV konsensus: posobie dlja vrachej. Vitebsk: VGMU, 2016; 190.
  11. Pimanov S.I., Makarenko E.V. Rekomendatsii Maastriht V Florentijskogo konsensusa po lecheniju helikobakternoj infektsii. Consilium Medicum. 2017: 19–27 (8.1. Gastroenterologija).
  12. Makarenka A.V., Pimanov S.I. Eradicftion Rate After Randomized Treatment in a Population with High Prevalence of Helicobacter pylori Infection. Helicobacter. 2005; 10: 535.
  13. Topchij N.V., Toporkov A.S. Primenenie Omitoksa v lechenii erozivno-jazvennyh porazhenij zheludka i dvenadtsatiperstnoj kishki. RMZh. 2011; 12: 748–52.
  14. Topchij N.V., Devjataeva Ju.M. Optimizatsija priema Omitoksa pri dispepsii. RMZh. 2012; 11: 542–8.
  15. Minushkin O.N., Zverkov I.V., Barkalova Ju.B. Opyt provedenija eradikatsionnogo lechenija (posledovatel'naja shema) jazvennoj bolezni dvenadtsatiperstnoj kishki. Meditsinskij alfavit. 2016; 34 (297): 50–2.
  16. Wang Z.H., Gao Q.Y., Fang J.Y. Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy. J. Clin. Gastroenterol. 2013; 47: 25–32.
  17. Pimanov S.I., Makarenko E.V., Dikareva E.A. Sobljudenie shemy terapii ingibitorami protonnogo nasosa pri postojannom prieme nesteroidnyh protivovospalitel'nyh sredstv. Terapevt. arh. 2015; 87 (4): 58–61.
  18. Maev I.V., Andreev D.N., Dicheva D.E., Goncharenko A.Ju. Farmakoterapevticheskie aspekty primenenija ingibitorov protonnoj pompy. Meditsinskij vestnik MVD. 2013; 3 (64): 9–14.
  19. [Maev I.V., Andreev D.N., Dicheva D.E., Goncharenko A. Ju. Farmakoterapevticheskie aspekty primenenija ingibitorov protonnoj pompy. Medicinskij vestnik MVD. 2013; 3 (64): 9–14 (in Russian)]
  20. Maev I.V., Andreev D.N., Goncharenko A.Ju., Dicheva D.T. Ingibitory protonnoj pompy kak osnova lechenija kislotozavisimyh zabolevanij. Sprav. poliklin. vracha. 2013; 7–8: 42–4.
  21. [Maev I.V., Andreev D.N., Goncharenko A.Ju., Dicheva D.T. Ingibitory protonnoj pompy kak osnova lechenija kislotozavisimyh zabolevanij. Sprav. poliklin. vracha. 2013; 7–8: 42–4 (in Russian)]
  22. Bljume H., Donat F., Varnke A., Shug B.S. Farmakokineticheskie lekarstvennye vzaimodejstvija s uchastiem ingibitorov protonnoj pompy. RMZh. 2009; 9: 622.
  23. [Bljume H., Donat F., Varnke A., Shug B.S. Farmakokineticheskie lekarstvennye vzaimodejstvija s uchastiem ingibitorov protonnoj pompy. RMZh. 2009; 9: 622 (in Russian)]
  24. Samsonov A.A. Ingibitory protonnoj pompy – preparaty vybora v lechenii kislotozavisimyh zabolevanij. Farmateka. 2007; 6: 10–5.
  25. [Samsonov A.A. Ingibitory protonnoj pompy – preparaty vybora v lechenii kislotozavisimyh zabolevanij. Farmateka. 2007; 6: 10–5 (in Russian)]